INTRODUCTION
Clouston syndrome or hidrotic ectodermal dysplasia is a rare genetic disease which involves the skin and annexes. 1 It is a form of ectodermal dysplasia initially described in 1895 and later reported in Canadian families by Clouston in 1939. 2 Ectodermal dysplasia describes a group of genetic diseases characterized by dysplasia of tissues that originate from the ectoderm and, occasionally, of tissues that originate from the mesoderm during embryonic development. 3 It occurs approximately in 1 in every 100,000 live births. 4 This disorder is divided into two main groups: hypohidrotic and hidrotic.
Hypohidrotic ectodermal dysplasia is the most common (80% of cases) and is characterized by absence or reduced number of sweat glands, associated with hypodontia, hypotrichosis and facial dimorphism. 4 On the other hand, in hidrotic ectodermal dysplasia there is no alteration in sweat glands and dentition is normal, but hair and nails are affected. 5 Hidrotic ectodermal dysplasia or Clouston syndrome is characterized by the main triad: nail dystrophy, generalized hypotrichosis and palmoplantar hyperkeratosis. 1 The affected patients present scarce hair and nail dystrophy, both noticeable since the first months of life. During infancy, hair is fragile and thin and its progressive loss may lead to total alopecia in puberty. Nails are whitish during childhood and gradually become dystrophic, thin and distally separated from the nail bed. Nail clubbing may occur. Palmoplantar keratoderma may develop in childhood and progress with age. Clinical characteristics vary greatly among individuals, even within the same family. 6 In addition, some patients may present skin hyperpigmentation, more evident on the joints. 5, 7 Strabismus, conjunctivitis, cataracts, deafness, polydactyly and syndactyly may occur. 7 Eccrine syringofibroadenomas have been reported in some patients. 8 Facial dimorphism is not present. 9 Clouston syndrome has a dominant autosomal pattern, therefore most patients have an affected family member, although new mutations have been reported as well. 6 Changes in gene GJB6, located in chromosome 13 (locus 13q11-q12) are responsible for the syndrome, since the gene is involved in the differentiation and growth of keratinocytes.
9 This gene codifies the cell-junction protein, connexin 30, a transmembrane protein which facilitates intercellular communication and is present in the stratum corneum, sweat glands and hair follicles. Connexins have an essential role in the control of cellular growth and development, besides responding to several stimuli.
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CASE REPORT
Female patient, 25 years old, from the state of São Paulo.
When she was ten months old, her mother who brought her to our clinic reporting that the child had had absence of hair, eyelashes and eyebrows since birth. An anatomopathological examination performed on the scalp revealed alopecia. One year later she presented desquamative lesions on her fingertips and dystrophic fingernails. At two years and six months of age, hyperkeratotic and desquamative plaques appeared on her palms.
At eight years of age the patient presented a clinical picture of total alopecia and nail dystrophy. Hyperkeratotic plaques, initially present on her palms, involved the soles of feet as well (Figure 1) . Besides, she presented a distal tapering of fingers, which at radiological examination showed reduction of soft tissues in distal extremities of fingers, acquiring a triangular configuration, and bone structures of normal appearance (Figure 2) . A biopsy was done which revealed absence of hair follicles, but sweat glands with normal features. The patient did not present changes in sudoresis, dentition or hearing.
When she was 14 years old, after being evaluated by a psychologist, emotional damage was observed and depression secondary to the pathology was diagnosed. Moreover, learning difficulties were noticed and light mental retardation diagnosed. At the time, the patient wore a hairpiece and presented remission of palmoplantar keratoderma after the introduction of topical keratolytics.
Patient treatment continued with multidisciplinary follow-up (dermatology, psychology and genetics). The same patient has two children which were not affected by the syndrome and are healthy. The patient's parents are phenotypically normal with no consanguinity. Genetic study did not reveal similar cases in the family. Currently at 25 years of age, the patient is periodically monitored and deals with her pathology in a very conscious way, continuing with the treatment for palmoplantar keratoderma (Figure 3 ). 
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